Analysts expect Xenon Pharmaceuticals Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% miss against the 1.72 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 7.50 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 356,030.44 | 2.99 M | 0.00 | 0.00 | 0.00 | 1.32 M | 1.82 M | 0.00 | 1.43 M | 0.00 | 0.00 | 2.50 M | 4.95 M | 53.93 M | 56.28 M | ||||||||||
| Low Estimate | 0.00 | 330,096.22 | 2.67 M | 0.00 | 0.00 | 0.00 | 1.22 M | 1.61 M | 0.00 | 1.25 M | 0.00 | 0.00 | 2.27 M | 4.19 M | 49.95 M | 46.52 M | ||||||||||
| Consensus Estimate | 0.00 | 343,063.33 | 2.83 M | 0.00 | 0.00 | 0.00 | 1.27 M | 1.72 M | 0.00 | 1.34 M | 0.00 | 0.00 | 2.39 M | 4.57 M | 51.94 M | 51.40 M |
Analysts expect Xenon Pharmaceuticals Inc. to report earnings per share of -1.10 for Q3 26, against a range of -1.19 to -1.01. The most recent reported quarter, Q2 26, came in at -1.11, a 8.3% beat against the -1.21 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.81 | -0.84 | -0.83 | -1.07 | -1.15 | -1.31 | -1.17 | -1.11 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.75 | -0.81 | -0.84 | -0.96 | -1.16 | -1.19 | -1.06 | -1.17 | -1.01 | -1.11 | -1.05 | -1.08 | -1.14 | -1.14 | -0.76 | -0.79 | ||||||||||
| Low Estimate | -0.85 | -0.95 | -0.90 | -1.08 | -1.26 | -1.29 | -1.16 | -1.25 | -1.19 | -1.31 | -1.27 | -1.28 | -1.28 | -1.30 | -0.86 | -0.95 | ||||||||||
| Consensus Estimate | -0.80 | -0.88 | -0.87 | -1.02 | -1.21 | -1.24 | -1.11 | -1.21 | -1.10 | -1.21 | -1.16 | -1.18 | -1.21 | -1.22 | -0.81 | -0.87 |
Pull Wall Street consensus for Xenon Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=XENE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "XENE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=XENE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();